Elke Eggenhofer
Overview
Explore the profile of Elke Eggenhofer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
2467
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Eggenhofer E, Proneth B
Transplantation
. 2024 Sep;
PMID: 39294870
The outcome after liver transplantation has improved in recent years, which can be attributed to superior storage and transportation conditions of the organs, as well as better peri- and postoperative...
2.
Stuve P, Nerb B, Harrer S, Wuttke M, Feuerer M, Junger H, et al.
Front Med (Lausanne)
. 2024 Feb;
10:1274482.
PMID: 38298516
No abstract available.
3.
Junger H, Muhlbauer M, Brennfleck F, Schurr L, Goetz M, Eggenhofer E, et al.
Clin Transplant
. 2022 Dec;
37(3):e14880.
PMID: 36522802
Background: Early patient and allograft survival after liver transplantation (LT) depend primarily on parenchymal function, but long-term allograft success relies often on biliary-tree function. We examined parameters related to cholangiocyte ...
4.
Mishima E, Ito J, Wu Z, Nakamura T, Wahida A, Doll S, et al.
Nature
. 2022 Aug;
608(7924):778-783.
PMID: 35922516
Ferroptosis, a non-apoptotic form of cell death marked by iron-dependent lipid peroxidation, has a key role in organ injury, degenerative disease and vulnerability of therapy-resistant cancers. Although substantial progress has...
5.
Eggenhofer E, Groell A, Junger H, Kasi A, Kroemer A, Geissler E, et al.
Int J Mol Sci
. 2021 Mar;
22(4).
PMID: 33670793
Liver transplantation (LTx) is often the only possible therapy for many end-stage liver diseases, but successful long-term transplant outcomes are limited by multiple factors, including ischemia reperfusion injury (IRI). This...
6.
Balam S, Kesselring R, Eggenhofer E, Blaimer S, Evert K, Evert M, et al.
Eur J Immunol
. 2020 Jul;
50(12):2041-2054.
PMID: 32640051
The purpose of this study was to elucidate whether DC NK lectin group receptor-1 (DNGR-1)-dependent cross-presentation of dead-cell-associated antigens occurs after transplantation and contributes to CD8 T cell responses, chronic...
7.
Weiss A, Lee O, Eggenhofer E, Geissler E, Korevaar S, Soeder Y, et al.
Stem Cells
. 2020 Feb;
38(6):797-807.
PMID: 32101344
Mesenchymal stem cells (MSCs) are used in various clinical and preclinical models for immunomodulation. However, it remains unclear how the immunomodulatory effect of MSC is communicated. MSC-induced immunomodulation is known...
8.
Rein-Fischboeck L, Haberl E, Bajraktari G, Feder S, Pohl R, Eggenhofer E, et al.
Exp Mol Pathol
. 2019 Dec;
113:104363.
PMID: 31881201
Non-alcoholic steatohepatitis (NASH) is characterized by immune cell infiltration. Loss of the scaffold protein alpha-syntrophin (SNTA) protected mice from hepatic inflammation in the methionine-choline-deficient (MCD) diet model. Here, we determined...
9.
Weiss T, Lupke M, Dayoub R, Geissler E, Schlitt H, Melter M, et al.
Cells
. 2019 Nov;
8(11).
PMID: 31718093
Hepatic ischemia reperfusion injury (IRI) is a major complication in liver resection and transplantation. Here, we analyzed the impact of recombinant human augmenter of liver regeneration (rALR), an anti-oxidative and...
10.
Gocze I, Ehehalt K, Zeman F, Riquelme P, Pfister K, Graf B, et al.
Crit Care
. 2018 Jul;
22(1):168.
PMID: 29973233
Background: Basic science data suggest that acute kidney injury (AKI) induced by ischemia-reperfusion injury (IRI) is an inflammatory process involving the adaptive immune response. Little is known about the T-cell...